Toby Arber
MD
Medical Oncologist, Lymphoma
👥Biography 个人简介
Dr. Toby Arber is a lymphoma specialist at UCL Cancer Institute who has contributed to trials of epcoritamab in relapsed/refractory DLBCL and other B-cell lymphomas. His research compares bispecific antibody therapy to CAR-T cell therapy and investigates biomarkers of response to CD20 x CD3 bispecifics. He is engaged in developing optimal combination strategies with bispecific antibodies in the UK lymphoma clinical trial network.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Toby Arber 的研究动态
Follow Toby Arber's research updates
留下邮箱，当我们发布与 Toby Arber（University College London Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment